Other Hepatitis C drug-developers' shares rally on the back of Bristol-Myers (BMY -1.1%) plans to buy Inhibitex (INHX +141%): Idenix Pharmaceuticals (IDIX +34%), Achillion Pharmaceuticals (ACHN +16%) and Vertex Pharmaceuticals (VRTX +4%).
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs